Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies

Physiological Genomics

Volumn 15, Issue , 2004, Pages 84-91

  Maguire, Colin T ^b   Wakimoto, Hiroko ^b   Patel, Vickas V ^c   Hammer, Peter E ^b   Gauvreau, Kimberlee ^b   Berul, Charles I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Genetics; Mice; Programmed stimulation; Ventricular tachycardia

Indexed keywords

ACCURACY; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRODE; ELECTROSTIMULATION; FEMALE; GENETIC ENGINEERING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; IN VITRO STUDY; INTRAVENOUS CATHETER; JUGULAR VEIN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STRAIN DIFFERENCE; WILD TYPE;

ANIMALIA; MURINAE;

EID: 0345871940     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00034.2003     Document Type: Article

References (47)

1. Alexander MA, Walsh EP, Saul JP, Epstein MR, and Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 10: 1033-1044, 1999.
2. Alexander MA and Berul CI. Ventricular arrhythmias: when to worry. Pediatr Cardiol 21: 532-541, 2000.
3. Arola A, Tuiminen J, Ruuskanen O, and Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101: 369-376, 1998.
4. Baker LC, London B, Choi BR, Koren G, and Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86: 396-407, 2000.
5. Berul CI, Aronovitz MJ, Wang PJ, and Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 94: 2641-2648, 1996.
6. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, and Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in αMHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest 99: 570-576, 1997.
7. Berul CI, Christe ME, Aronovitz MJ, Maguire CT, Seidman CE, Seidman JG, and Mendelsohn ME. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J Interv Card Electrophysiol 2: 7-14, 1998.
8. Berul CI and Wang PJ. In vivo electrophysiologic studies in mice. In: Cardiovascular Physiology in the Genetically Engineered Mouse (2nd ed.), edited by Hoit BD and Walsh RA. Boston: Kluwer Academic, 2001, p. 237-256.
9. Berul CI, McConnell BK, Wakimoto H, Moskowitz IP, Maguire CT, Semsarian C, Vargas MM, Gehrmann J, Seidman CE, and Seidman JG. Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin-binding protein C gene. Circulation 104: 2734-2739, 2001.
10. Bevilacqua LM, Maguire CT, Seidman JG, Seidman CE, and Berul CI. QT dispersion in α-myosin heavy-chain familial hypertrophic cardiomyopathy mice. Pediatr Res 45: 643-647, 1999.
11. Bevilacqua LM, Simon AM, Maguire CT, Gehrmann J, Wakimoto H, Paul DL, and Berul CI. A targeted disruption in connexin40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol 4: 459-467, 2000.
12. Brodsky MA, Mitchell LB, Halperin BD, Raitt MH, Hallstrom AP, and AVID Investigators. Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am Heart J 144: 478-484, 2002.
13. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, and Hafley G. Electrophysiologic testing to identify patients with coronary artery disease at risk for sudden death. N Engl J Med 342: 1937-1945, 2000.
14. Drici MD, Baker L, Plan P, Barhanin J, Romey G, and Salama G. Mice display sex differences in halothane-induced polymorphic ventricular tachycardia. Circulation 106: 497-503, 2002.
15. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, and Saffitz JE, and Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 51: 681-690, 2001.
16. Fananapazir L and Epstein SE. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol 67: 280-287, 1991.
17. Friedman RA, Moak JP, and Garson A Jr. Clinical course of dilated cardiomyopathy in children. J Am Coll Cardiol 18: 152-156, 1991.
18. Gehrmann J and Berul CI. Cardiac electrophysiology in genetically engineered mice. J Cardiovasc Electrophysiol 11: 354-368, 2000.
19. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, and Berul CI. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol 279: H733-H740, 2000.
20. Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, and Berul CI. Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol 96: 237-250, 2001.
21. Gehrmann J, Meister M, Maguire CT, Hammer PE, Neer EJ, Berul CI, and Mende U. Impaired parasympathetic heart rate control in transgenic mice with a reduction of functional G-protein β-subunits. Am J Physiol Heart Circ Physiol 282: H445-H456, 2002; 10.1152/ajpheart.00565.2001.
22. Geibel A, Brugada P, Zehender M, Stevenson W, Waldecker B, and Wellens HJ. Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy. Am J Cardiol 60: 738-739, 1987.
23. Guo W, Li H, London B, and Nerbonne JM. Functional consequences of elimination ofi(to,f) and i(to,s): early afterdepolarizations, atrioventricular block, and ventricular arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 α subunit. Circ Res 87: 73-79, 2000.
24. Jeron A, Mitchell GF, Zhou J, Murata M, London B, Buckett P, Wiviott SD, and Koren G. Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q-T phenotype. Am J Physiol Heart Circ Physiol 278: H1891-H1898, 2000.
25. Josephson ME. Should ICDs be implanted in all patients with dilated cardiomyopathy and unexplained syncope? J Am Coll Cardiol 33: 1969-1970, 1999.
26. Kanter RJ. Risk assessment of patients having congenital heart disease using electrophysiological testing. J Cardiovasc Electrophysiol 10. 1045-1048, 1999.
27. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, and Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 8: 299-302, 1998.
28. Korte T, Fuchs M, Guener Z, v Bonin J, de Sousa M, Niehaus M, Tebbenjohanns J, and Drexler H. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J Interv Card Electrophysiol 6: 121-132, 2002.
29. Kuck KH, Kunze KP, Schluter M, Nienaber CA, and Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy: results in patients with and without cardiac arrest or syncope. Eur Heart J 9: 177-185, 1988.
30. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, and Chien KR. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107: 801-813, 2001.
31. Lerner DL, Yamada KA, Schuessler RB, and Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101: 547-552, 2000.
32. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF, and Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N-terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci USA 95: 2926-2931, 1998.
33. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM, and Salama G. Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284: H431-H441, 2003. First published October 17, 2002; 10.1152/ajpheart.00431.2002.
34. Nguyen-Tran VT, Kubalak SW, Minamisawa S, Fiset C, Wollert KC, Brown AB, Ruiz-Lozano P, Barrere-Lemaire S, Kondo R, Norman LW, Gourdie RG, Rahme MM, Feld GK, Clark RB, Giles WR, and Chien KR. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell 102: 671-682, 2000.
35. Nwangwu PU, Holeslaw TL, and Stohs SJ. A rapid in vivo technique for preliminary screening of antiarrhythmic agents in mice. Arch Int Pharmacodyn Ther 229: 219-226, 1977.
36. Papadatos GA, Wallerstein PM, Head CE, Rateliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, and Grace AA. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene SCN5A. Proc Natl Acad Sci USA 99: 6210-6215, 2002.
37. Pedersen DH, Zipes DP, Foster PR, and Troup PJ. Ventricular tachycardia and ventricular fibrillation in a young population. Circulation 60: 988-997, 1979.
38. Rakhit A, Maguire CT, Wakimoto H, Gehrmann J, Li GK, Kelly RA, Michel T, and Berul CI. In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. J Cardiovasc Electrophysiol 12: 1295-1301, 2001.
39. Rakhit A and Berul CI. Transgenic electrophysiology and small animal models. In: Foundations of Cardiac Arrhythmias, edited by Spooner PM and Rosen MR. New York: Marcel Dekker, 2001, p. 651-664.
40. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, and Vincent GM. Multiple mechanisms in the long QT syndrome: current knowledge, gaps, and future directions. Circulation 94: 1996-2012, 1996.
41. Silka MJ, Kron J, Cutler JE, and McAnulty JH. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years and younger. Am J Cardiol 66: 826-830, 1990.
42. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, and Saffitz JE. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 97: 686-691, 1998.
43. Wakimoto H, Maguire CT, Kovoor P, Hammer P, Gehrmann J, Triedman JT, and Berul CI. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res 50: 463-473, 2001.
44. Wakimoto H, Kasahara H, Maguire CT, Izumo S, and Berul CI. Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA non-binding mutant Nkx2.5. J Cardiovasc Electrophysiol 13: 682-688, 2002.
45. Wu Y, Temple J, Zhang R, Dzhura I, Zhang W, Trimble R, Roden DM, Passier R, Olson EN, Colbran RJ, and Anderson ME. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 106: 1288-1293, 2002.
46. Zhou YY and Liu TF. Comparison of early afterdepolarization induced by cesium chloride in mouse atrial and ventricular fibers. Acta Pharmacol Sin 16: 261-265, 1995.
47. Zipes DP and Wellens HJ. Sudden cardiac death. Circulation 98: 2334-2351, 1998.